Prostate cancer is the most common malignancy in males. Men aged 50 years and older are
recommended to undergo an annual digital rectal examination (DRE) and determination of …

Despite recent improvements in detection and treatment, prostate cancer continues to be the
most common malignancy and the second leading cause of cancer-related mortality. Thus …

Prostate cancer is the most common non-cutaneous malignancy among American men.
Imaging has recently become more important in detection of prostate cancer since screening …

Prostate cancer is the most common malignancy in men, in general. Most patients
diagnosed with prostate cancer have localized disease confined to the prostate. A small …

Prostate Cancer Imaging: What We Already Know and What Is on the Horizon | RadioGraphics
RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All Journals …

The current diagnosis and management of prostate cancer is largely based on the use of
serum prostate-specific antigen (PSA) and pathologic risk factors such as Gleason score …

Prostate cancer is the most common malignancy in the world and, except for skin cancer, the
most frequently diagnosed. It has been suggested by autopsy studies that approximately …

For men residing within the United States, prostate cancer is second only to lung cancer in
cancer mortality and second in incidence to nonmelanomatous skin cancers. The …

The diagnosis of prostate cancer is suggested by elevated prostate-specific antigen but is
confirmed by histopathological examination of ultrasound-guided transrectal biopsies …

The development of prostate cancer imaging is rapidly evolving, with many changes to the
way patients are diagnosed, staged, and monitored for recurrence following treatment. New …